Cargando…

Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies

Obtaining full-length antibody heavy- and light-chain variable regions from individual B cells at scale remains a challenging problem. Here we use high-throughput single-cell B-cell receptor sequencing (scBCR-seq) to obtain accurately paired full-length variable regions in a massively parallel fashi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Leonard D., Chen, Ying-Jiun J., Wu, Jia, Chaudhuri, Subhra, Hsiao, Yi-Chun, Schneider, Kellen, Hoi, Kam Hon, Lin, Zhonghua, Guerrero, Steve, Jaiswal, Bijay S., Stinson, Jeremy, Antony, Aju, Pahuja, Kanika Bajaj, Seshasayee, Dhaya, Modrusan, Zora, Hötzel, Isidro, Seshagiri, Somasekar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689056/
https://www.ncbi.nlm.nih.gov/pubmed/31428692
http://dx.doi.org/10.1038/s42003-019-0551-y
Descripción
Sumario:Obtaining full-length antibody heavy- and light-chain variable regions from individual B cells at scale remains a challenging problem. Here we use high-throughput single-cell B-cell receptor sequencing (scBCR-seq) to obtain accurately paired full-length variable regions in a massively parallel fashion. We sequenced more than 250,000 B cells from rat, mouse and human repertoires to characterize their lineages and expansion. In addition, we immunized rats with chicken ovalbumin and profiled antigen-reactive B cells from lymph nodes of immunized animals. The scBCR-seq data recovered 81% (n = 56/69) of B-cell lineages identified from hybridomas generated from the same set of B cells subjected to scBCR-seq. Importantly, scBCR-seq identified an additional 710 candidate lineages not recovered as hybridomas. We synthesized, expressed and tested 93 clones from the identified lineages and found that 99% (n = 92/93) of the clones were antigen-reactive. Our results establish scBCR-seq as a powerful tool for antibody discovery.